Restore Vision Inc.

About

Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy for retinitis pigmentosa. In collaboration with the Keio University School of Medicine, have a promising product with high sensitivity enabling patients to see even under low light conditions. It has proven to have competitive advantages at the pre-clinical stage, and are currently working towards an early clinical data acquisition.

Founders

• Yusaku Katada

  CEO

Product

Gene therapy drug using adeno-associated viral vector by intravitreal administration. Irrespective of genotype of retinitis pigmentosa, it can be expected to have a semi-permanent therapeutic effect by single administration.

Achievement in alliance

Advisors with experience in ophthalmic AAV gene therapy drug development and CMC.

Profile

Web

https://restore-vis.com/

Contact

yusakukatada[_at_]restore-vis.com

Crunch Base